SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-096584
Filing Date
2023-04-10
Accepted
2023-04-10 16:38:35
Documents
4
Group Members
AVENTIS INCZEST ACQUISITION SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d691623dsctota.htm SC TO-T/A 32015
2 EX-99.(A)(5)(C) d691623dex99a5c.htm EX-99.A5C 14737
3 GRAPHIC g691623dsp7.jpg GRAPHIC 1290
4 GRAPHIC g691623g0407211923395.jpg GRAPHIC 2601
  Complete submission text file 0001193125-23-096584.txt   54272
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Subject) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90545 | Film No.: 23811545
SIC: 2834 Pharmaceutical Preparations